Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient

Subtype switching in breast cancer brain metastases: a multicenter analysis

(2020) Alexander F C Hulsbergen et al.   NEURO-ONCOLOGY

Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding

(2019) Sofia Gkountela et al.   CELL

Physical Principles of Membrane Shape Regulation by the Glycocalyx

(2019) Carolyn R. Shurer et al.   CELL

Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment

(2019) Yidi Qu et al.   Molecular Cancer

Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer

(2018) Nicole Blanchette-Farra et al.   ONCOGENE

Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53

(2018) Fei Zhou et al.   Cancer Cell International

Breast cancer

(2017) Nadia Harbeck et al.   LANCET

HER2-positive breast cancer

(2017) Sibylle Loibl et al.   LANCET

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis

(2017) Wenzhe Li et al.   Scientific Reports

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors

(2016) Shom Goel et al.   CANCER CELL

Basal/HER2 breast carcinomas

(2013) Begoña Martin-Castillo et al.   CELL CYCLE

Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

(2012) A Gallardo et al.   BRITISH JOURNAL OF CANCER

Resistance to Trastuzumab in Breast Cancer

(2009) P. R. Pohlmann et al.   CLINICAL CANCER RESEARCH

Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies

(2009) Ralf Hass et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH